Letter: impact of Epstein-Barr virus serological status on clinical outcomes in adult patients with inflammatory bowel disease – authors’ reply.

Letter: impact of Epstein-Barr virus serological status on clinical outcomes in adult patients with inflammatory bowel disease – authors’ reply.

Aliment Pharmacol Ther. 2019 Feb;49(4):477-478

Authors: de Francisco R, Castaño-García A, Riestra S

PMID: 30689254 [PubMed – in process]

PubMed Link: https://www.ncbi.nlm.nih.gov/pubmed/30689254?dopt=Abstract